[HTML][HTML] Decellularized extracellular matrix biomaterials for regenerative therapies: Advances, challenges and clinical prospects

AA Golebiowska, JT Intravaia, VM Sathe, SG Kumbar… - Bioactive Materials, 2024 - Elsevier
Tissue engineering and regenerative medicine have shown potential in the repair and
regeneration of tissues and organs via the use of engineered biomaterials and scaffolds …

Decellularized xenografts in regenerative medicine: From processing to clinical application

H Capella‐Monsonís, DI Zeugolis - Xenotransplantation, 2021 - Wiley Online Library
Decellularized xenografts are an inherent component of regenerative medicine. Their
preserved structure, mechanical integrity and biofunctional composition have well …

[HTML][HTML] Antibiotic-eluting envelopes to prevent cardiac-implantable electronic device infection: past, present, and future

K Xiang, JN Catanzaro, C Elayi, ZE Garrigos… - Cureus, 2021 - ncbi.nlm.nih.gov
Objective: Cardiac-implantable electronic device (CIED) infections are associated with
significant morbidity and mortality. In this review, we describe the risk factors and …

Research Progress on Extracellular Matrix-Based Composite Materials in Antibacterial Field

D Cai, T Liu, W Weng, X Zhu - Biomaterials Research, 2025 - spj.science.org
Due to their exceptional cell compatibility, biodegradability, and capacity to trigger tissue
regeneration, extracellular matrix (ECM) materials have drawn considerable attention in …

Prevention and management of cardiac implantable electronic device infections: state-of-the-art and future directions

K Mahtani, E Maclean, RJ Schilling - Heart, Lung and Circulation, 2022 - Elsevier
Cardiac implantable electronic device (CIED) infection is an increasingly common
complication of device therapy. CIED infection confers significant patient morbidity and …

Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular‐matrix envelope

MR Sohail, Z Esquer Garrigos, CS Elayi… - Pacing and Clinical …, 2020 - Wiley Online Library
Background Using synthetic antibiotic‐eluting envelope (ABE) is an effective intervention for
prevention of cardiovascular implantable electronic device (CIED) infection. The biologic …

Cardiovascular implantable electronic device infection and new insights about correlation between pro-inflammatory markers and heart failure: A systematic literature …

S Zerbo, G Perrone, C Bilotta, V Adelfio… - Frontiers in …, 2021 - frontiersin.org
Introduction: Surgical approaches to treat patients with abnormal pro-inflammatory
parameters remain controversial, and the debate on the correlation between hematological …

Management of cardiac implantable electronic devices in the presence of left ventricular assist devices

V Parikh, A Sauer, PA Friedman, SH Sheldon - Heart Rhythm, 2018 - Elsevier
Left ventricular assist devices (LVAD) are increasingly used in the management of patients
with advanced heart failure. Many of these patients have or will be considered for a cardiac …

[HTML][HTML] Patient profiles in the utilization of the CanGaroo® envelope

H Nayak, AD Beaser, ZA Aziz - Cureus, 2021 - ncbi.nlm.nih.gov
Background The CanGaroo® Envelope (Aziyo Biologics, Silver Spring, MD) is intended to
securely hold a cardiovascular implantable electronic device (CIED) to create a stable …

Use of acellular biologic matrix envelope for cardiac implantable electronic device placement to correct migration into submuscular breast implant pocket

P Terry, K Bilchick, CA Campbell - Archives of Plastic Surgery, 2023 - thieme-connect.com
Breast implants whether used for cosmetic or reconstructive purposes can be placed in
pockets either above or below the pectoralis major muscle, depending on clinical …